TRAF6 and cardiomyopathy: Previous research has demonstrated that TRAF6 plays a central role as a mediator in sepsis-associated cardiomyopathy through the Akt signaling, which becomes heightened and exacerbates cardiac injury in LPS-treated mice [58].